The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding

  title={The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding},
  author={Adam N. Rosenthal and Theodore A. Panoskaltsis and Trudy Smith and William Patrick Soutter},
  journal={BJOG: An International Journal of Obstetrics \& Gynaecology},
Objectives To document the frequency of pathology in women who complain of postcoital bleeding. To determine whether negative cervical cytology excludes serious pathology in women with postcoital bleeding. To determine whether postcoital bleeding increases the risk of serious pathology in women with an abnormal smear. 

The incidence of cervical cancer in women with postcoital bleeding and abnormal appearance of the cervix referred through the 2‐week wait pathway in the United Kingdom: A retrospective cohort study

To determine the incidence of cervical cancer in women referred through the 2‐week‐wait pathway for postcoital bleeding and abnormal appearance of the cervix, a retrospective cohort study is conducted.

Investigation and management of postcoital bleeding

It is essential that all gynaecologists are aware of referral pathways for suspected cervical malignancy and knowledge of how to investigate and manage postcoital bleeding is imperative to provide optimal care and ensure patient safety.

Evaluation of women presenting with postcoital bleeding by cytology and colposcopy


Invasive cancer is rare in women with postcoital bleeding and should be regarded as an indication of high risk so all women must undergo colposcopic examination.

Abnormal vaginal bleeding in women with gynaecological malignancies.

  • T. AdamsL. Denny
  • Medicine
    Best practice & research. Clinical obstetrics & gynaecology
  • 2017

A clinico-pathological study of postcoital bleeding

It is concluded that CIN may not always be asymptomatic and the incidence of cervical or endometrial cancer is low in women with PCB, and the first report of associatedendometrial polyps contributing to PCB is reported.

Evaluation of women with postcoital bleeding by clinical examination, papsmear, colposcopy and histopathology of cervix

Cervical cancer is the second most common cancer in the women throughout the world and there are multiple etiologies among which most common are benign cervicitis, ectropion or cervical polyps.

Should women with postcoital bleeding be referred for colposcopy?- A review

Electronic searches of literature published between 1980 and 2014 were undertaken using MEDLINE, Embase, CINHAL, and the Cochrane Database of Systemic reviews. Search items included: post coital

Frequency of abnormal Pap smear in patients presenting with postcoital bleeding in Tertiary Care Hospital, Karachi, Pakistan.

Because of the high frequency of abnormal Pap smear associated with postcoital bleeding in this population, cervical screening and strict monitoring are suggested as the important screening indications.



Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic.

Cervical erosion should not be regarded as pathological in asymptomatic women, nor should it be assumed necessarily to be the cause of symptoms in women with genitourinary complaints.

Histopathological findings in women with postmenopausal bleeding

Investigation of endometrial histopathology in a geographically defined population of women presenting with postmenopausal bleeding finds no significant differences between menopausal and non-menopausal women.

Why do we continue to take unnecessary smears?

A questionnaire survey of all general practices and family planning doctors in Manchester Health Authority was undertaken to determine why many more smears are taken in primary care than are

Multifactorial audit of invasive cervical cancer: key lessons for the National Screening Programme.

  • D. Slater
  • Medicine
    Journal of clinical pathology
  • 1995
Why cervical cancer occurs after a true negative smear requires research and women aged over 65 with no smear must be targeted.